Fellowship · San Francisco, CA
Sponsored by University of California (San Francisco) School of Medicine
Hepatocellular carcinoma.
Nature reviews. Disease primers · 2021 · 5,588 citations · Kate Kelley
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Journal of hepatology · 2022 · 3,643 citations · Kate Kelley
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology (Baltimore, Md.) · 2023 · 1,671 citations · Neil Mehta
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update.
Journal of hepatology · 2026 · 154 citations · Kate Kelley
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
NEJM evidence · 2022 · 1,418 citations · Kate Kelley
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2023 · 986 citations · Kate Kelley
Global epidemiology of cirrhosis - aetiology, trends and predictions.
Nature reviews. Gastroenterology & hepatology · 2023 · 668 citations · Norah Terrault
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 1,286 citations · Mustafa Arain